Traditional Chinese medicine composition for treating chronic cardiac failure and preparation method thereof

Abstract

The invention discloses a traditional Chinese medicine composition for treating chronic cardiac failure. The traditional Chinese medicine composition is prepared from the following raw materials by weight: 1-25g of red ginseng, 5-40g of astragalus membranaceus, 5-28g of cassia twig, 25-70g of euonymusfortunei, 5-40g of radix fici simplicissimae, 5-28g of ligusticum wallichii, 5-40g of poria cocos, 5-28g of semen lepidii, 5-28g of radix polygonati officinalis and 3-20g of pseudo-ginseng. The invention also discloses a preparation method of the traditional Chinese medicine composition for treating chronic cardiac failure. The raw materials of the traditional Chinese medicine composition are simple and easily available, and the traditional Chinese medicine composition for treating chronic cardiac failure has the functions of tonifying yin of qi, dredging channels and warming yang to promote diuresis, and is good in curative effect, quick to take effect and small in toxic and side effects in the treatment process of chronic cardiac failure. The traditional Chinese medicine composition has positive meaning in exerting characteristics of heroic medicines and improving a clinic prevention and treatment level of CHF.

Description

technical field [0001] The invention relates to the technical field of traditional Chinese medicines, in particular to a traditional Chinese medicine composition for treating chronic heart failure and a preparation method thereof. Background technique [0002] Chronic heart failure (CHF) is a group of syndromes in which various organic or functional heart diseases impair ventricular filling or ejection ability, and is the final stage of the development of various cardiovascular system diseases. According to statistics, there are currently about 4.5 million CHF patients in China, which is a very large patient population. With the widespread application of Western medicine prevention and treatment guidelines for CHF, the one-year survival rate of CHF patients has gradually increased, and the success rate of rescue in acute exacerbation of CHF has also been significantly improved, but the long-term effect is still not ideal. At present, even if the treatment is fully followed ...

AI Technical Summary

Problems solved by technology

However, there is still a lack of systematic research on preparations of Zhuang medicine for the prevention and treatment of CHF. If we can develop effective medicines for the treatment of CHF with the characteristics of Zhuang medicine, it will be of positive significance to give full play to the characteristics of Zhuang medicine and improve the level of clinical prevention and treatment of CHF.